Directorate Change

RNS Number : 0157H
IP Group PLC
14 June 2013
 



 

FOR RELEASE ON

                                                   14 June 2013

IP Group plc - Directorate change

 

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property based businesses, announces that Dr Alison Fielding, the Company's Chief Operating Officer, is stepping down as an executive director with effect from 30 June.

 

While Dr Fielding is leaving the IP Group Board for health reasons, she will remain with the Group on a part-time basis in a role that will enable the Group to continue to leverage her significant expertise. Dr Fielding will also retain her existing directorships of IP Group portfolio companies.

 

Alan Aubrey, Chief Executive of IP Group, said: "On behalf of the Board and the Company, I would like to thank Ali for her immense contribution to the Group over the past decade and we all look forward to working with her in her new role."

 

For more information, please contact:

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive Officer            

+44 (0) 20 7444 0050

Liz Vaughan-Adams, Communications   

+44 (0) 20 7444 0062 / +44 (0) 7979 853 802

liz.vadams@ipgroupplc.com

FTI Consulting


Ben  Atwell, John Dineen

+44 (0) 20 7831 3113

 

Notes for editors

 

About IP Group

 

IP Group is a leading UK intellectual property ("IP") commercialisation company, developing technology innovations primarily from its research intensive partner universities. The Group offers more than traditional venture capital, providing its companies with access to business building expertise, networks, recruitment and business support.

 

The Company's portfolio comprises holdings in over 70 companies including Oxford Nanopore Technologies, the DNA sequencing development company, Revolymer, best known for its removable chewing gum and Xeros, which has received many accolades for its revolutionary clothes washing techniques with a much reduced requirement for water.

 

The portfolio includes early stage to mature businesses and has exposure to five main sectors - Energy & Renewables, Medical Equipment & Supplies, Pharma & Biotech, IT & Communications and Chemicals & Materials. To date, fifteen of the portfolio companies IP Group has backed have listed on the AIM market of the London Stock Exchange and one on ISDX.

 

Founded in 2001, IP Group listed on AIM in October 2003 and moved to the Official List in June 2006.

 

For more information, please visit our website at www.ipgroupplc.com.

 

Ends


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFJMITMBBBBIJ

Companies

IP Group (IPO)
UK 100

Latest directors dealings